Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: A systematic review and meta-analysis

BMJ Open

Volumn 7, Issue 5, 2017, Pages

  Adeloye, Davies ^a,b   Ige, Janet O ^c   Aderemi, Adewale V ^d   Adeleye, Ngozi ^a   Amoo, Emmanuel O ^a   Auta, Asa ^e   Oni, Gbolahan ^a  

^a Covenant University ^*  (Nigeria)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^d OSUN STATE UNIVERSITY   (Nigeria)

^e UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; DIABETIC FOOT; EPIDEMIOLOGICAL DATA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MORTALITY RATE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SYSTEMATIC REVIEW; UNITED NATIONS; GLUCOSE INTOLERANCE; META ANALYSIS; MORTALITY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; NIGERIA; PREDIABETIC STATE; PREVALENCE; RISK FACTORS;

EID: 85018899974     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-015424     Document Type: Article

References (79)

1. International Diabetes Federation. Diabetes Atlas. 1st ed. Brussels, Belgium: International Diabetes Federation, 2000.
2. International Diabetes Federation. Diabetes Atlas. 2nd ed. Belgium: International Diabetes Federation, 2003.
3. International Diabetes Federation. Diabetes Atlas. 3rd ed. Belgium: International Diabetes Federation, 2006.
4. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21.
5. International Diabetes Federation. Diabetes Atlas. 4th ed. Belgium: International Diabetes Federation, 2009.
6. International Diabetes Federation. Diabetes Atlas. 7th ed. Belgium: International Diabetes Federation, 2015.
7. World Health Organisation. Global report on diabetes. 2016 http://who.int/diabetes/global-report/en/ (accessed 07 April 2016).
8. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49.
9. Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet 2006;368:1689-95.
10. Mbanya JC, Motala AA, Sobngwi E, et al. Diabetes in sub-Saharan Africa. Lancet 2010;375:2254-66.
11. Ogbera AO, Ekpebegh C. Diabetes mellitus in Nigeria: the past, present and future. World J Diabetes 2014;5:905-11.
12. Akinkugbe OO. Non-communicable diseases in Nigeria: national survey (Final Report) on hypertension, coronary heart disease, diabetes mellitus, haemoglobinopathies, G6PD deficiency and anaemia. Lagos: Federal Ministry of Health and Social Services - National Expert Committee on Non-Communicable Diseases, 1997.
13. Onyemelukwe GC. National survey of noncommunicable diseases (Southwest zone). Abuja: Federal Ministry of Health - National Expert Committee on Non-Communicable Diseases, 2003.
14. Chinenye S, Young E. State of Diabetes Care in Nigeria: a Review. The Nigerian Health Journal 2011;11:101-6.
15. World Health Organisation. Nigeria- Diabetes country profiles. Geneva, Switzerland: World Health Organization, 2016.
16. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland: WHO, 2006.
17. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
18. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000;23:1108-12.
19. World Health Organization. Diabetes Mellitus: report of a WHO study group. Technical Report Series No.727 Geneva, Switzerland: WHO 1985.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
21. Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and metaanalysis. Lancet Glob Health 2014;2:e174-e181.
22. Pai M, McCulloch M, Gorman JD, et al. Systematic reviews and meta-analyses: an illustrated, step-by-step guide. Natl Med J India 2004;17:86-95.
23. Guyatt GH, Rennie D. Users' guides to the medical literature: a manual for evidence-based clinical practice. Chicago: AMA Press, 2002.
24. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
26. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collaboration: Oxford, 2011.
27. Adeloye D, Basquill C, Aderemi AV, et al. An estimate of the prevalence of hypertension in Nigeria: a systematic review and metaanalysis. J Hypertens 2015;33:230-42.
28. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLoS One 2014;9:e104300.
29. Erasmus RT, Fakeye T, Olukoga O, et al. Prevalence of diabetes mellitus in a Nigerian population. Trans R Soc Trop Med Hyg 1989;83:417-8.
30. Oghagbon EK, Okesina AB, Biliaminu SA. Prevalence of hypertension and associated variables in paid workers in Ilorin, Nigeria. Niger J Clin Pract 2008;11:342-6.
31. Tagurum YO, Okoh EO, Inalegwu E, et al. Non-communicable diseases: prevalence and risk factors among adults in a rural community in Plateau State, Nigeria. Int J Biomed Res 2015;6:228-34.
32. Gezawa ID, Puepet FH, Mubi BM, et al. Socio-demographic and anthropometric risk factors for type 2 diabetes in Maiduguri, North-Eastern Nigeria. Sahel Medical Journal 2015;18:1-7.
33. Okesina AB, Oparinde DP, Akindoyin KA, et al. Prevalence of some risk factors of coronary heart disease in a rural nigerian population. East Afr Med J 1999;76:212-6.
34. Dahiru T, Jibo A, Hassan AA, et al. Prevalence of diabetes in a semiurban community in Northern Nigeria. Niger J Med 2008;17:414-6.
35. Sabir AA, Isezuo SA, Ohwovoriole AE. Dysglycaemia and its risk factors in an Urban Fulani population of Northern Nigeria. West Afr J Med 2011;30:325-30.
36. Sabir A, Ohwovoriole A, Isezuo S, et al. Type 2 diabetes mellitus and its risk factors among the rural Fulanis of Northern Nigeria. Ann Afr Med 2013;12:217-22.
37. Sani MU, Wahab KW, Yusuf BO, et al. Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study. BMC Res Notes 2010;3:11.
38. Aguocha BU, Ukpabi JO, Onyeonoro UU, et al. Pattern of diabetic mortality in a tertiary health facility in south-eastern Nigeria. AJDM 2013;21:14-16.
39. Ejike C, Uka NK, Nwachukwu SO. Diabetes and pre-diabetes in adult Nigerians: prevalence, and correlations of blood glucose concentrations with measures of obesity. Afr J Biochem Res 2015;9:55-60.
40. Ejim EC, Okafor CI, Emehel A, et al. Prevalence of cardiovascular risk factors in the middle-aged and elderly population of a Nigerian rural community. J Trop Med 2011;2011:1-6.
41. Ngwogu KO, Iek M, Ngwogu AC. Morbidity pattern of diabetic admissions at the Abia State University Teaching Hospital, Aba, Nigeria. IJCR 2012;1:49-53.
42. Nwatu CB, Ofoegbu EN, Unachukwu CN, et al. Prevalence of prediabetes and associated risk factors in a rural Nigerian community. Int J Diab Dev Ctries 2015;2015:1-7.
43. Ogah OS, Madukwe OO, Onyeonoro UU, et al. Cardiovascular risk factors and non-communicable diseases in Abia state, Nigeria: report of a community-based survey. Int J Med Biomed Res 2013;2:57-68.
44. Okpechi IG, ChukwuonyeI Tiffin N, et al. Blood pressure gradients and cardiovascular risk factors in urban and rural populations in Abia State South Eastern Nigeria using the WHO STEPwise approach. PLoS One 2013;8:e73403.
45. U. Osuji C, A. Nzerem B, E. Dioka C, et al. Prevalence of diabetes mellitus in a group of women attending 'August meeting' at Naze South East Nigeria. J Diabetes Mellitus 2012;2:321-6.
46. Ekpenyong CE, Akpan UP, Ibu JO, et al. Gender and age specific prevalence and associated risk factors of type 2 diabetes mellitus in Uyo metropolis, South Eastern Nigeria. Diabetologia Croatica 2012;41:17-28.
47. Alikor CA, Emem-Chioma PC. Epidemiology of diabetes and impaired fasting glucose in a rural community of nigerian Niger delta region. Niger J Med 2015;24:114-24.
48. Enang OE, Otu AA, Essien OE, et al. Prevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, Nigeria. BMJ Open Diabetes Res Care 2014;2:e000032.
49. Isara AR, Okundia PO. The burden of hypertension and diabetes mellitus in rural communities in southern Nigeria. Pan Afr Med J 2015;20.
50. Nwafor A, Owhoji A. Prevalence of diabetes mellitus among Nigerians in Port Harcourt correlates with socioeconomic status. J Appl Sci Environ Mgmt 2001;5:75-7.
51. Nyenwe EA, Odia OJ, Ihekwaba AE, et al. Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract 2003;62:177-85.
52. Oguoma VM, Nwose EU, Skinner TC, et al. Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to CVD risks screening. BMC Public Health 2015;15:397.
53. Umoh VA, Otu AA, Enang OE, et al. The pattern of diabetic admissions in UCTH Calabar, South Eastern Nigeria: a five year review. TNHJ 2012;12:7-11.
54. Ogbera O. Burden of diabetic illness in an urban hospital in Nigeria. Trop Doct 2007;37:153-4.
55. Ajayi EA, Ajayi AO. Pattern and outcome of diabetic admissions at a federal medical center: a 5-year review. Ann Afr Med 2009;8:271-5.
56. Ogbera AO, Chinenye S, Onyekwere A, et al. Prognostic indices of diabetes mortality. Ethn Dis 2007;17:721-5.
57. Akintunde AA, Salawu AA, Opadijo OG. Prevalence of traditional cardiovascular risk factors among staff of Ladoke Akintola University of Technology, Ogbomoso, Nigeria. Niger J Clin Pract 2014;17:750-5.
58. Pheabian Akinwale O, John Oyefara L, Adejoh P, et al. Survey of hypertension, Diabetes and Obesity in three Nigerian Urban Slums. Iran J Public Health 2013;42:972-9.
59. Alebiosu OC, Familoni OB, Ogunsemi OO, et al. Community based diabetes risk assessment in ogun state, Nigeria (World Diabetes Foundation project 08-321). Indian J Endocrinol Metab 2013;17:653-8.
60. Ayodele OE, Okunola OO, Afolabi MO, et al. Prevalence of hypertension, diabetes and chronic kidney disease in participants of the 2009 World Kidney Day screening exercise in Southwest Nigeria. HKJN 2011;13:55-63.
61. Ezenwaka CE, Akanji AO, Akanji BO, et al. The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern Nigerians. Atherosclerosis 1997;128:201-11.
62. Ogunmola OJ, Olaifa AO, Oladapo OO, et al. Prevalence of cardiovascular risk factors among adults without obvious cardiovascular disease in a rural community in Ekiti State, Southwest Nigeria. BMC Cardiovasc Disord 2013;13:89.
63. Ohwovoriole AE, Kuti JA, Kabiawu SI. Casual blood glucose levels and prevalence of undiscovered diabetes mellitus in Lagos Metropolis Nigerians. Diabetes Res Clin Pract 1988;4:153-8.
64. Ojewale LY, Adejumo PO. Type 2 Diabetes Mellitus and impaired fasting blood glucose in Urban South Western Nigeria. Int J Diabetes & Metab 2012;21:9-12.
65. Oladapo OO, Salako L, Sodiq O, et al. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western nigerian population: a population-based survey. Cardiovasc J Afr 2010;21:26-31.
66. Owoaje EE, Rotimi CN, Kaufman JS, et al. Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J 1997;74:299-302.
67. Oluyombo R, Olamoyegun MA, Olaifa O, et al. Cardiovascular risk factors in semi-urban communities in southwest Nigeria: patterns and prevalence. J Epidemiol Glob Health 2015;5:167-74.
68. Olatunbosun ST, Ojo PO, Fineberg NS, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigeria. J Natl Med Assoc 1998;90:293-301.
69. Rotimi CN, Cooper RS, Okosun IS, et al. Prevalence of diabetes and impaired glucose tolerance in Nigerians, Jamaicans and US blacks. Ethn Dis 1999;9:190-200.
70. Kyari F, Tafida A, Sivasubramaniam S, et al. Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health 2014;14:1299.
71. Abubakari AR, Bhopal RS. Systematic review on the prevalence of diabetes, overweight/obesity and physical inactivity in Ghanaians and Nigerians. Public Health 2008;122:173-82.
72. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
73. Mbanya JC, Kengne AP, Assah F. Diabetes care in Africa. Lancet 2006;368:1628-9.
74. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010;2:1.
75. World Bank. World development report. New York: Oxford University Press for the World Bank, 1993.
76. United Nations. World Population Prospects, the 2010 Revision: definition of regions. 2012 http://esa.un.org/unpd/wpp/Excel-Data/definition-of-regions.htm (accessed 24 July 2012)).
77. Aspray TJ, Unwin N. Diabetes in sub-Saharan Africa. Adv Exp Med Biol 2001;498:21-6.
78. Kirigia JM, Sambo HB, Sambo LG, et al. Economic burden of diabetes mellitus in the WHO African region. BMC Int Health Hum Rights 2009;9:6.
79. Mbanya JC, Mbanya D. Diabetes cost in sub-Saharan Africa. J Cardiovasc Risk 2003;10:191-3.